Serina Therapeutics (SER) Receivables - Net (2017 - 2024)
Serina Therapeutics (SER) posted Receivables - Net of $14000.0 for Q3 2024, down 72.55% sequentially from $51000.0 in Q2 2024, and down 79.1% YoY from $67000.0 in Q4 2023.
Serina Therapeutics (SER) Receivables - Net (2017 - 2024) Analysis & Trends
Serina Therapeutics has reported Receivables - Net for 8 years, with the latest figure at $14000.0 in Q3 2024.
- Quarterly Receivables - Net fell 79.1% year-over-year to $14000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $14000.0 (down 79.1% YoY) and the FY2022 annual result came in at $4000.0, down 84.0% from the prior year.
- Receivables - Net eased to $14000.0 in Q3 2024 per SER's latest filing, from $51000.0 in the prior quarter.
- Over five years, Receivables - Net peaked at $366000.0 in Q1 2020 and troughed at $1000.0 in Q3 2022.
- A 5-year average of $88352.9 and a median of $25000.0 in 2021 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2022 and 2023: Receivables - Net sank 95.83% in 2022, then soared 6600.0% in 2023.
- Over 5 years, Receivables - Net stood at $326000.0 in 2020, then plunged by 92.33% to $25000.0 in 2021, then tumbled by 84.0% to $4000.0 in 2022, then soared by 1575.0% to $67000.0 in 2023, then tumbled by 79.1% to $14000.0 in 2024.
- According to Business Quant data, Receivables - Net over the past three periods registered $14000.0, $51000.0, and $65000.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Serina Therapeutics | 43.44 Mn | 20.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 14,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 51,000.00 |
| Jun 30, 2024 | 51,000.00 |
| Mar 31, 2024 | 65,000.00 |
| Mar 31, 2024 | 65,000.00 |
| Sep 30, 2023 | 67,000.00 |
| Sep 30, 2023 | 67,000.00 |
| Jun 30, 2023 | 6,000.00 |
| Jun 30, 2023 | 6,000.00 |
| Mar 31, 2023 | 6,000.00 |
| Mar 31, 2023 | 6,000.00 |
| Dec 31, 2022 | 4,000.00 |
| Dec 31, 2022 | 4,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Jun 30, 2022 | 12,000.00 |
| Jun 30, 2022 | 12,000.00 |
| Dec 31, 2021 | 25,000.00 |
| Dec 31, 2021 | 25,000.00 |